222 related articles for article (PubMed ID: 37035854)
1. Metallo-antiviral aspirants:
Mehrotra R; Shukla SN; Gaur P
Eur J Med Chem Rep; 2023 Aug; 8():100104. PubMed ID: 37035854
[TBL] [Abstract][Full Text] [Related]
2. What is holding back the development of antiviral metallodrugs? A literature overview and implications for SARS-CoV-2 therapeutics and future viral outbreaks.
de Paiva REF; Marçal Neto A; Santos IA; Jardim ACG; Corbi PP; Bergamini FRG
Dalton Trans; 2020 Nov; 49(45):16004-16033. PubMed ID: 33030464
[TBL] [Abstract][Full Text] [Related]
3. Metallo therapeutics for COVID-19. Exploiting metal-based compounds for the discovery of new antiviral drugs.
Cirri D; Pratesi A; Marzo T; Messori L
Expert Opin Drug Discov; 2021 Jan; 16(1):39-46. PubMed ID: 32915656
[TBL] [Abstract][Full Text] [Related]
4. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Molecular scaffolds from mother nature as possible lead compounds in drug design and discovery against coronaviruses: A landscape analysis of published literature and molecular docking studies.
Khursheed A; Jain V; Rasool A; Rather MA; Malik NA; Shalla AH
Microb Pathog; 2021 Aug; 157():104933. PubMed ID: 33984466
[TBL] [Abstract][Full Text] [Related]
7. Metal Complexes as Antiviral Agents for SARS-CoV-2.
Karges J; Cohen SM
Chembiochem; 2021 Aug; 22(16):2600-2607. PubMed ID: 34002456
[TBL] [Abstract][Full Text] [Related]
8. Metal-based strategies for the fight against COVID-19.
Li H; Yuan S; Wei X; Sun H
Chem Commun (Camb); 2022 Jul; 58(54):7466-7482. PubMed ID: 35730442
[TBL] [Abstract][Full Text] [Related]
9. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.
Aljabali AAA; Bakshi HA; Satija S; Metha M; Prasher P; Ennab RM; Chellappan DK; Gupta G; Negi P; Goyal R; Sharma A; Mishra V; Dureja H; Dua K; Tambuwala MM
Pharm Nanotechnol; 2020; 8(4):323-353. PubMed ID: 32811406
[TBL] [Abstract][Full Text] [Related]
10. Drug Repurposing: A Strategy for Discovering Inhibitors against Emerging Viral Infections.
Dos Santos Nascimento IJ; de Aquino TM; da Silva-Júnior EF
Curr Med Chem; 2021; 28(15):2887-2942. PubMed ID: 32787752
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic developments for SARS-CoV-2 infection-Molecular mechanisms of action of antivirals and strategies for mitigating resistance in emerging variants in clinical practice.
Săndulescu O; Apostolescu CG; Preoțescu LL; Streinu-Cercel A; Săndulescu M
Front Microbiol; 2023; 14():1132501. PubMed ID: 36937282
[TBL] [Abstract][Full Text] [Related]
12. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
Froggatt HM; Heaton BE; Heaton NS
J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
[TBL] [Abstract][Full Text] [Related]
13. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
Patil AM; Göthert JR; Khairnar V
Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930
[TBL] [Abstract][Full Text] [Related]
14. Antiviral drug discovery: preparing for the next pandemic.
Adamson CS; Chibale K; Goss RJM; Jaspars M; Newman DJ; Dorrington RA
Chem Soc Rev; 2021 Mar; 50(6):3647-3655. PubMed ID: 33524090
[TBL] [Abstract][Full Text] [Related]
15. Bridging informatics and medicinal inorganic chemistry: Toward a database of metallodrugs and metallodrug candidates.
Medina-Franco JL; López-López E; Andrade E; Ruiz-Azuara L; Frei A; Guan D; Zuegg J; Blaskovich MAT
Drug Discov Today; 2022 May; 27(5):1420-1430. PubMed ID: 35227887
[TBL] [Abstract][Full Text] [Related]
16. Antiviral Potential of Nanoparticles-Can Nanoparticles Fight Against Coronaviruses?
Gurunathan S; Qasim M; Choi Y; Do JT; Park C; Hong K; Kim JH; Song H
Nanomaterials (Basel); 2020 Aug; 10(9):. PubMed ID: 32825737
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive review on the prevailing COVID-19 therapeutics and the potential of repurposing SARS-CoV-1 candidate drugs to target SARS-CoV-2 as a fast-track treatment and prevention option.
Sabarimurugan S; Dharmarajan A; Warrier S; Subramanian M; Swaminathan R
Ann Transl Med; 2020 Oct; 8(19):1247. PubMed ID: 33178779
[TBL] [Abstract][Full Text] [Related]
18. Review of studies on SARS-CoV-2 infection inhibitors.
Michalski A; Wójcicka P; Bielawska-Drózd A; Bartoszcze M
Ann Agric Environ Med; 2021 Dec; 28(4):541-550. PubMed ID: 34969209
[TBL] [Abstract][Full Text] [Related]
19. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
Abdurrahman L; Fang X; Zhang Y
Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
[TBL] [Abstract][Full Text] [Related]
20. Antiviral Drug Discovery for the Treatment of COVID-19 Infections.
Ng TI; Correia I; Seagal J; DeGoey DA; Schrimpf MR; Hardee DJ; Noey EL; Kati WM
Viruses; 2022 May; 14(5):. PubMed ID: 35632703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
